Evidence map›Paper›PMID 38762221›Full record

ArticleJournal of public health (Oxford, England)2024

Impact of the 2022 African Cup of Nations mass-gathering event on the COVID-19 epidemic in Garoua, Cameroon.

Jean-Luc Berland, Hermann Njifon, Emilie Westeel, Henri Moumbeket, Florence Komurian-Pradel, Pauliana Ilouga, Richard Njouom, Ronald Perraut

Abstract read
In one paragraph

Article in Journal of public health (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jean-Luc BerlandScientific and Medical Department, Fondation Merieux, 69002 Lyon, France.ORCID 0000-0002-6337-3715
Hermann NjifonCentre Pasteur du Cameroun, Annexe de Garoua, Garoua, Cameroon.
Emilie WesteelScientific and Medical Department, Fondation Merieux, 69002 Lyon, France.
Henri MoumbeketCentre Pasteur du Cameroun, Yaounde, Cameroon.
Florence Komurian-PradelScientific and Medical Department, Fondation Merieux, 69002 Lyon, France.
Pauliana IlougaCentre Pasteur du Cameroun, Yaounde, Cameroon.
Richard NjouomCentre Pasteur du Cameroun, Yaounde, Cameroon.
Ronald PerrautCentre Pasteur du Cameroun, Annexe de Garoua, Garoua, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe 2022 African Cup of Nations (AFCON) took place in Cameroon from January 9th to February 5th, 2022, including Garoua in the north. We aimed to measure the impact of this event on the local COVID-19 epidemic given the implementation of a preventive strategy based on a health pass.

methodsAll players, staff and fans involved in the AFCON event were screened with PCR tests. Symptomatic cases were also continuously monitored in the general population and screened for variants of concern. Daily numbers of confirmed cases were compared to neighboring countries numbers retrieved from a public domain source.

resultsIn total, 1479 and 2481 tests were performed in the general population and on asymptomatic AFCON attendees, respectively. From the latter, 12.5% were PCR-positive; 97% were infected with Omicron, with no significant difference compared to the passive program (G-test, P value = 0.162). Surveillance indicated the AFCON did not increase the number of symptomatic PCR-positive cases in the general population compared to neighboring countries.

conclusionsThough the COVID-19 epidemic was fueled by asymptomatic cases infected with the Omicron variant at the time, the non-therapeutic preventive measures implemented for AFCON mitigated an increase in the epidemic in the local population.

Indexed as

COVID-19Mass GatheringsSARS-CoV-2AdultCameroonFemaleHumansMaleCOVID-19outdoor eventtransmission

Identifiers

PMID38762221
PMCPMC11358624

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.